Weekly Roundup
COVID-19 Vaccine Development, Policy, and Public Perception in the United States
|
|
This plan provides elected and appointed officials with the tools to create, implement, and support a vaccination campaign that works with BIPOC communities to remedy COVID-19 impacts, prevent even more health burdens, lay the foundation for unbiased healthcare delivery, and enable broader social change and durable community-level opportunities.
|
|
People, Perceptions, and Polls
|
|
REPORT
COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020. From September to December 2020, intent to receive COVID-19 vaccination increased from 39.4% to 49.1% among adults and across all priority groups, and nonintent decreased from 38.1% to 32.1%. Despite decreases in nonintent from September to December, younger adults, women, non-Hispanic Black adults, adults living in nonmetropolitan areas, and adults with less education and income, and without health insurance continue to have the highest estimates of nonintent to receive COVID-19 vaccination. (CDC, 2/12/21)
See also:
|
|
WEBINAR
Overcoming COVID Vaccine Hesitancy in Immigrant Communities. While efforts to administer the COVID-19 vaccine are ramping up across the country, there is a dramatic rise in misinformation being shared. As a result, many individuals and families are hesitant to receive the vaccine, and this is especially true in many immigrant communities. The webinar will take place on February 17, 2021, 2 PM EST. Registration is required. (Welcoming America, 2/21)
|
|
Research, Development, and Clinical Practice
|
|
BLOG
How You Make an Adenovirus Vaccine. The other day I had a look at the process used to make the mRNA vaccines, so I thought it would be a good idea to do the same for the adenovirus vector ones, such as J&J, Oxford/AstraZeneca, CanSino, Gamaleya et al. It’s a different system, with its own advantages and disadvantages, and that’s the broad story of scale-up manufacturing all the way: tradeoffs at every turn. (Science Magazine, 2/8/21)
|
|
NEWS
A Few Covid Vaccine Recipients Developed a Rare Blood Disorder. It is not known whether this blood disorder is related to the Covid vaccines. More than 31 million people in the United States have received at least one dose, and 36 similar cases had been reported to the government’s Vaccine Adverse Event Reporting System, VAERS, by the end of January. The cases involved either the Pfizer-BioNTech or Moderna vaccine, the only two authorized so far for emergency use in the United States. (New York Times, 2/8/21)
|
|
REPORT
COVID-19 and the cost of vaccine nationalism. Experience shows that, in response to pandemics, national governments tend to follow their own interests instead of pursuing a more globally coordinated approach. This nationalistic behavior could have negative consequences on how well the COVID-19 global pandemic is managed and contained. (RAND, 2/21)
|
|
COMMENTARY
Reducing Health Disparities Requires Financing People-Centered Primary Care. Spurred by the nationwide reckoning on the interlinked challenges of coronavirus disease 2019 (COVID-19) and racism, health systems, hospitals, and physician groups are mobilizing to promote health equity. This mobilization is long overdue and urgently required, as we attempt to protect and heal our patients in an era of worsening divisiveness amid the ongoing pandemic. (JAMA, 2/1/21)
|
|
NEWS
What Are Vaccine Passports and How Would They Work? With millions being vaccinated against Covid-19 every day, some political and business leaders are suggesting nations can help get life back to normal by rolling out a so-called vaccine passport: an easily accessible and verifiable certification that a person’s been inoculated. (Bloomberg, 2/9/21)
|
|
NEWS
Lessons from the U.S.’s Rocky Vaccine Rollout. The United States is blessed with highly trained, excellent, and compassionate care providers and terrific research and development that has led to novel medical treatments. Yet, despite these many advantages, its health care system has an inability to deliver that excellence to patients in a consistent, high-quality, and cost-effective manner. (Harvard Business Review, 1/28/21)
See also:
|
|
NEWS
'Vax trash' increases as worldwide COVID-19 vaccination effort ramps up. As coronavirus vaccines roll out across the world, we're seeing an increase in discarded medical products heading to the dump. Many are calling it vax trash. There’s a lot of it. "Really what we’re talking about are syringes from the (coronavirus) vaccination programs, the needles," said Dr. Amesh Adalja, Senior Scholar at the Johns Hopkins Center for Health Security. That’s hundreds of millions of those needles. (KCBS Radio, 2/8/21)
|
|
CONFERENCE
National Forum on COVID-19 Vaccine. In support of the Biden-Harris administration’s National Strategy for the COVID-19 Response and Pandemic Preparedness, the Centers for Disease Control and Prevention is organizing a virtual National Forum on COVID-19 Vaccine that will bring together practitioners from national, state, tribal, local, and territorial levels who are engaged in vaccinating communities across the nation. The forum will take place February 22-24, 2021. (CDC, 2/21)
|
|
This newsletter supports CommuniVax, a research coalition convened by the
Johns Hopkins Center for Health Security and the Texas State University Department of Anthropology,
with support from the Chan Zuckerberg Initiative.
|
|
|
|
|
|
|